Clinical trial · Observational
Nodal Upstaging in VATS Anatomical Resections for NSCLC
Cohort Analysis of Nodal Upstaging in the Era of Increase of VATS Anatomical Resections for NSCLC
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study investigates peropeative nodal upstaging during anatomical resections for non-small-cell-lung-cancer in an era of rising numbers of VATS anatomical resections. In case of comparable study groups, unchanged pretreatment staging and equal quality of pathologic examination, lymph node upstaging is a marker of surgical quality and can be used to study the quality of a new surgical technique.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (3)
- label
- open thoracotomy
- description
- In the first cohort(20007-2009) almost all patients where operated through a thoracotomy.
- label
- Early VATS
- description
- In a second cohort, (2010-2011) the experience with vats was early.
- label
- Standardized VATS
- description
- In the third period (2012-2013), a standardized vats technique with extensive intrapulmonary and mediastinal lymphadenectomy was used.
Primary outcomes (1)
- measure
- proportion of N upstaging
- timeFrame
- at time of surgical resection
- description
- clinical N0 to pathological N1 clinical N0 to pathological N2 clinical N1 to pathological N2
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All cN0, cN1 patients that underwent segmentectomy, lobectomy, sleeve lobectomy for NSCLC. Exclusion Criteria: * cN2 * cM+ * Pneumonectomy * Previous lung cancer surgery - lymphadenectomy * Neo-adjunvant therapy * Lung Tx * Bilateral lesions
References
Publications (0)
Data not yet available